# Geodon (Ziprasidone) for Posttraumatic Stress Disorder

> **NCT00208208** · PHASE4 · COMPLETED · sponsor: **Creighton University** · enrollment: 80 (—)

## Conditions studied

- Posttraumatic Stress Disorder
- Post-Traumatic Stress Disorder
- PTSD

## Interventions

- **DRUG:** Ziprasidone

## Key facts

- **NCT ID:** NCT00208208
- **Lead sponsor:** Creighton University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 80 (—)
- **Last updated:** 2006-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00208208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00208208, "Geodon (Ziprasidone) for Posttraumatic Stress Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00208208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*